<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26337721</article-id>
      <article-id pub-id-type="pmc">4559176</article-id>
      <article-id pub-id-type="publisher-id">386</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-015-0386-x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ichiyanagi</surname>
            <given-names>Osamu</given-names>
          </name>
          <address>
            <phone>+81-23-628-5368</phone>
            <email>o.ichiyanagi@med.id.yamagata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ito</surname>
            <given-names>Hiromi</given-names>
          </name>
          <address>
            <email>ito.hiromi@med.id.yamagata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takai</surname>
            <given-names>Satoshi</given-names>
          </name>
          <address>
            <email>sacchin_64@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Naito</surname>
            <given-names>Sei</given-names>
          </name>
          <address>
            <email>seinaitoh@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kato</surname>
            <given-names>Tomoyuki</given-names>
          </name>
          <address>
            <email>kato-t@med.id.yamagata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nagaoka</surname>
            <given-names>Akira</given-names>
          </name>
          <address>
            <email>nakira@med.id.yamagata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamakawa</surname>
            <given-names>Mitsunori</given-names>
          </name>
          <address>
            <email>myamakaw@med.id.yamagata-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Urology, Yamagata University Faculty of Medicine, 2-2-2, Iida-Nishi, Yamagata City, Yamagata prefecture 990-9585 Japan </aff>
        <aff id="Aff2"><label/>Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, 2-2-2, Iida-Nishi, Yamagata City, Yamagata prefecture 990-9585 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>4</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>4</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>155</elocation-id>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Ichiyanagi et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Solitary fibrous tumor (SFT) is a rare neoplasm composed of mesenchymal-derived spindle cells. Although SFT occurs anywhere in the body, they most frequently affects the thoracic region. Here, we reported an extremely rare case of an extrathoracic SFT occurring primarily in the kidney. To our knowledge, little information has been described on the immunohistochemistry (IHC) and genetics of renal SFT.</p>
        <p>A 41-year old Japanese female came to our hospital for further examination of a left kidney mass detected incidentally with ultrasound. Extensive investigation of the tumor, including physical, laboratory, and image examinations led to a clinical diagnosis of renal cancer (cT1aN0M0), which were in most parts imbedded in the lower polar parenchyma. The patient underwent laparoscopic radical nephrectomy. The mass was diagnosed pathologically as SFT originating from the kidney, but not as renal carcinoma. Microscopically, the tumor was composed of spindle-shape cells distributed variably in dense collagenous stroma and had a focal hemangiopericytomatous staghorn-like vascular pattern. Mitotic figures, atypical structures, necrosis and hemorrhage were not identified. No adjuvant therapies were given postoperatively. The patient has been free of tumor recurrence for 25&#xA0;months since the surgery. IHC revealed that the tumor diffusely expressed CD34, CD99, Bcl2, PAX8, NAB2, STAT6, and GRIA2. The tumor stained negatively for desmin, S-100, c-Kit, CK-AE1/AE3, CDK4 and MDM2. A NAB2-SATA6 gene fusion was detected in tumor cells by reverse transcription-polymerase chain reaction, direct sequencing, and an <italic>in situ</italic> proximity ligation brightfield assay. The gene fusion occurred as an 831&#xA0;bp truncation of exon 2 in <italic>NAB2</italic> connected to the beginning of exon 3 in <italic>STAT6</italic>. We have reported a case of GRIA2 and PAX8-positive SFT occurring primarily in the kidney with such <italic>NAB2</italic>-<italic>STAT6</italic> gene fusion for the first time. Diffuse expression of PAX8 in the tumor might present with a renal origin. Reportedly, benign histology of SFT cannot necessarily predict favorable clinical prognosis. Genetic alterations recently identified in SFT could possibly refer to risk stratification for tumor recurrence. However, malignant preponderance of extrathoracic SFT over thoracic SFT remains unexplained so far. Long-term follow-up after surgery should be performed in the present case.</p>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13000-015-0386-x) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>A solitary fibrous tumor (SFT) is a rare spindle cell neoplasm originating from mesenchymal cells [<xref ref-type="bibr" rid="CR1">1</xref>]. It was first depicted in the pleura of the lung by Klemperer et al. [<xref ref-type="bibr" rid="CR2">2</xref>] in 1931. To date, SFTs have been reported in various locations other than the pleura, including the meninges, orbit, neck, nose, paranasal cavity, thyroid, mediastinum, adrenal gland, liver, pancreas, retroperitoneum, spermatic cord, skin, extremities, uterine cervix, prostate, urinary bladder and kidney [<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>]. Among these affected sites, renal SFT, first reported by Gelb et al. [<xref ref-type="bibr" rid="CR6">6</xref>] in 1996, is very rare. Approximately only 50 cases have been described in the literature [<xref ref-type="bibr" rid="CR7">7</xref>]. Microscopy and immunohistochemistry (IHC) of surgically resected or biopsied tumor specimens is essential for SFT diagnosis, as imaging modalities, including ultrasonography (USG), computed tomography (CT) and magnetic resonance imaging are unable to definitively differentiate SFT from renal cell carcinoma (RCC) in most cases [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Although SFT is generally regarded as a benign tumor, up to 10 % of extrapleural SFTs exhibit malignant behavior, such invasion, recurrence, or distant metastasis [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR11">11</xref>]. SFT in the kidney is mostly benign but has malignant potential. Recently, there has been an increase in the number of reports of malignant SFT, including metastasis to lymph nodes [<xref ref-type="bibr" rid="CR12">12</xref>], lung [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], liver [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], pancreas [<xref ref-type="bibr" rid="CR11">11</xref>] and bone [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], local recurrence [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], peritoneal implantation [<xref ref-type="bibr" rid="CR3">3</xref>], and invasion to renal vein [<xref ref-type="bibr" rid="CR18">18</xref>]. Microscopically, the diagnostic criteria for malignant SFT is the presence of increased cellularity with crowded and overlapping nuclei, pleomorphism, necrosis and hemorrhage, increased mitotic activity more than four mitoses per ten high power fields (HPFs) [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. However, some SFT patients without the malignant features in microscopy presented with distant metastasis [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] and local invasion [<xref ref-type="bibr" rid="CR18">18</xref>], suggesting that non-malignant histology in SFT could not necessarily predict benign behavior and favorable prognosis in clinical practice.</p>
      <p>Recently, <italic>NAB2-STAT6</italic> gene fusions have been reported in SFT [<xref ref-type="bibr" rid="CR20">20</xref>&#x2013;<xref ref-type="bibr" rid="CR22">22</xref>]. Variations of <italic>NAB2-STAT6</italic> gene fusions could affect the clinical features, histology, and prognosis of SFT [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. IHC of the diagnostic markers STAT6 and GRIA2 would be important in differentiating SFT from other soft tissue tumors [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. To our knowledge, however, genetic and IHC analyses have only been performed using tissue specimens from SFTs in areas of the body other than the kidney, possibly because renal SFT is extremely rare. In the present paper, we report a patient who underwent radical nephrectomy for treatment of cT1a RCC, which was postoperatively diagnosed by pathology as renal SFT with non-malignant nature. <italic>NAB2-STAT6</italic> gene fusions and IHC with anti-NAB2, -STAT6, -GRIA2 and -PAX8 antibodies were also examined.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <sec id="Sec3">
        <title>Clinical summary</title>
        <p>A 41-year-old Japanese woman visited our institution for further examination of a left renal mass with a diameter of 3.3&#xA0;cm detected incidentally by abdominal USG at a municipal health workup for citizens 2 months prior. She had been asymptomatic without any history of local discomfort, hematuria, fever, sweat, or weight loss. Her past and family histories were unremarkable, except that she had taken oral contraceptives regularly for 10 years. She was a never-smoker.</p>
        <p>In a physical examination, the patient was normotensive and not obese, with a height of 156.3&#xA0;cm and weight of 49.5&#xA0;kg. Laboratory tests, including blood cell counts, biochemistry, C-reactive protein, and urinalysis, showed unremarkable results. A solid, well-demarcated, and heterogeneous mass lesion was observed in the lower pole of the left kidney by USG, accompanied by arterial signals of blood flow within the tumor on color-Doppler ultrasound (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). Plain CT of the tumor showed a faintly higher attenuation than the outer parenchyma of the left kidney (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). The tumor, mostly endophylic in the renal parenchyma, measured 38.0&#x2009;&#xD7;&#x2009;37.5&#x2009;&#xD7;&#x2009;33.6&#xA0;mm in size in contrast-enhanced CT. Intratumoral serpentine blood vessels were noted in the hypoenhanced tumor tissue in the arterial phase of dynamic CT (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>). Subsequently well-enhanced, the tumor showed early washout of contrast media in the delayed phase (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). There was no evidence of local invasion to the adjacent tissues or metastasis to local lymph nodes or distant organs in CT of the chest, abdomen, and pelvis.<fig id="Fig1"><label>Fig. 1</label><caption><p>Clinical images of the left renal tumor. A mass with clear margin and mostly endophylic growth was detected in the lower and posterior part of the left kidney. <bold>a</bold> The tumor presented with a non-cystic mass of a heterogeneous nature in ultrasound. Color Doppler imaging showed hypervascularity in the tumor. <bold>b</bold>, <bold>c</bold>, <bold>d</bold>) Dynamic computed tomography of the left renal tumor. <bold>b</bold> Image before administration of the contrast medium. <bold>c</bold> Early phase of enhanced computed tomography. A blood vessel was visualized in the tumor. <bold>d</bold> The tumor showed earlier washout of enhancement than the adjacent normal renal parenchyma</p></caption><graphic xlink:href="13000_2015_386_Fig1_HTML" id="MO1"/></fig></p>
        <p>Preoperatively, the patient was diagnosed with papillary type I or chromophobe RCC at clinical stage I (cT1aN0M0). The R.E.N.A.L. nephrometry score was 1&#x2009;+&#x2009;2&#x2009;+&#x2009;3&#x2009;+&#x2009;p&#x2009;+&#x2009;1&#x2009;=&#x2009;7p for R, E, N, A and L points, respectively, showing moderate complexity of the tumor mass [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Endophylic lesions in the kidney are generally considered to be more challenging to surgical resection than exophylic ones [<xref ref-type="bibr" rid="CR28">28</xref>]. The patient consequently underwent laparoscopic left radical nephrectomy. The postoperative course was not eventful. No adjuvant treatment was administered after surgery and the patient has been free of tumor recurrence or metastasis for 25&#xA0;months.</p>
      </sec>
      <sec id="Sec4">
        <title>Pathological findings of the surgical specimen</title>
        <p>Macroscopically, the tumor mass, which was buried mostly in the renal parenchyma and displayed endophylic growth, was situated in the lower pole of the left kidney, as shown on USG and CT images. The resected margins of the tumor mass were clear. There was no invasion into the renal capsule, perinephric fat tissues, and the renal parenchyma adjacent to the mass. The excised section of the tumor was gray to white in color and firm upon palpation. Necrosis and hemorrhage were absent on gross inspection (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Cut section of the resected kidney and tumor. Upon gross inspection, the tumor located in the lower and dorsal part of the left kidney had expansive growth, was well-demarcated from the renal parenchyma, and had a whitish color. Neither necrosis nor bleeding were observed on the cut surface of the tumor</p></caption><graphic xlink:href="13000_2015_386_Fig2_HTML" id="MO2"/></fig></p>
        <p>Microscopically, the tumor was composed of spindle-shape cells distributed variably in the dense collagenous stroma (so-called &#x201C;patternless pattern&#x201D;) and had a focal hemangiopericytomatous staghorn-like vascular pattern (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref> and <xref rid="Fig3" ref-type="fig">b</xref>). Mitotic figures and atypical structures were not identified. There were no necrotic and hemorrhagic findings in the tumor. In IHC, the tumor cells were negative for desmin, S-100, c-Kit, CK-AE1/AE3, EMA, CD31, CD117, CDK4, MDM2 and p63. The cells were diffusely positive for CD34, CD99, Bcl2, vimentin, &#x3B1;-smooth muscle actin, NAB2, STAT6, and GRIA2 (Figs.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref> and <xref rid="Fig4" ref-type="fig">4</xref>) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Ki-67 levels were very low in the tumor nuclei (0.6 to 0.7 %) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3d</xref>). The microscopic findings were consistent with classic SFT without malignant histology as described by previous studies [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. PAX8, a marker for renal differentiation, was also positive diffusely in the tumor nuclei (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Microscopy of conventional staining of pathological specimens. The tumor had slit-like vessels (<bold>a</bold>, <italic>arrows</italic>) and expansive compression of the adjacent normal renal tissues (<bold>a</bold>, <italic>arrowheads</italic>). The tumor constituted spindle-shaped cells situated in variable directions in dense collagenous stroma (<bold>b</bold>) and had diffuse CD34 expression throughout the tumor (<bold>c</bold>). A small number of tumor nuclei were positive for Ki-67, with a Ki-67 labeling index of 0.6&#x2013;0.7 % (<bold>d</bold>, <italic>arrow</italic>). Mitosis, atypia, necrosis and hemorrhage were not found by microscopy in the tumor (<bold>a</bold> to <bold>d</bold>). These findings about the kidney tumor are consistent with a classic SFT without malignant nature. Original magnification: x20, x400, x200 and x100 for A, B, C and D, respectively. HE, hematoxylin and eosin</p></caption><graphic xlink:href="13000_2015_386_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Immunohistochemistry for NAB2 (<bold>a</bold>), STAT6 (<bold>b</bold>), and GRIA2 (<bold>c</bold>). The tumor cells diffusely expressed the antigens. <bold>d</bold> shows the <italic>NAB2-STAT6</italic> gene fusion in the renal SFT cells in an <italic>in situ</italic> proximity ligation brightfield assay, as represented by red dots (<italic>arrows</italic>). PLA, proximity ligation brightfield assay. Original magnification: x200 for <bold>a</bold>, <bold>b</bold> and <bold>c</bold>, and x400 for <bold>d</bold>, respectively</p></caption><graphic xlink:href="13000_2015_386_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Immunohistochemistry for PAX8. The PAX8 antigen was expressed diffusely in the nuclei of the tumor cells (with spindle-shape nuclei) and the renal tubules (with round nuclei, <italic>arrow</italic>). Original magnification: x200</p></caption><graphic xlink:href="13000_2015_386_Fig5_HTML" id="MO5"/></fig></p>
        <p>Two cases of pleural SFTs with non-malignant nature, obtained from the pathological archives in our institution, were used as positive controls for examining reactivity for various antibodies, including NAB2, STAT6, and GRIA2. One case showed positive staining for both STAT6 and GRAI2, while the other was STAT6-negative but GRIA2-positive (data not shown). The result was similar to a report by Vivero et al. [<xref ref-type="bibr" rid="CR4">4</xref>]. The former case was positive for NAB2, but the latter was negative (data not shown).</p>
        <p>Paraffin-embedded formalin-fixed specimens used for routine pathological investigation were available for IHC of the SFT in the present study. IHC protocols using various primary antibodies are described elsewhere in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p>
      </sec>
      <sec id="Sec5">
        <title>Identification of a NAB2-STAT6 gene fusion in the SFT</title>
        <p>Fresh frozen tumor specimens resected surgically from the patient at the Yamagata University Hospital were used for detection of a <italic>NAB2-STAT6</italic> gene fusion by quantitative reverse transcription-polymerase chain reaction (RT-PCR) and immunoblotting, as reported elsewhere [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In addition to the SFT mass, normal renal tissue was compared as a control. PCR primers were designed with reference to previous papers [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Structures of the primers used in this study are shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>. <italic>In situ</italic> proximity ligation brightfield assay (PLA) was performed for IHC detection of nuclear <italic>NAB2-STAT6</italic> fusion in the SFT using a Duolink&#xAE; kit together with anti-NAB2 and -STAT6 primary antibodies. A brief description of the methodology of RT-PCR, direct sequencing and <italic>in situ</italic> PLA in the present study is presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p>
        <p>The results of RT-PCR and direct sequencing are presented in Additional file <xref rid="MOESM3" ref-type="media">3</xref> (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S1) and Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, respectively. RT-PCR with various combination of forward and reverse PCR primers indicates that a <italic>NAB2-STAT6</italic> gene fusion occurred at some point between exon1 of <italic>NAB2</italic> and exon5 of <italic>STAT6</italic> (Additional file <xref rid="MOESM3" ref-type="media">3</xref>). Direct sequencing demonstrated that the fusion junction occurred between <italic>NAB2</italic> in exon2, truncated at 831&#xA0;kb, and the beginning of <italic>STAT6</italic> in exon3 (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref> and Additional file <xref rid="MOESM4" ref-type="media">4</xref>). In addition, an <italic>NAB2-STAT6</italic> fusion gene was identified as red nuclear dots in an <italic>in situ</italic> PLA assay of pathological sections of the renal SFT (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4d</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><p>Direct sequencing of the <italic>NAB2-STAT6</italic> gene fusion. The junction of the gene fusion were found at 831&#xA0;bp within <italic>NAB2</italic> in exon 2 and the beginning of <italic>STAT6</italic> in exon 3</p></caption><graphic xlink:href="13000_2015_386_Fig6_HTML" id="MO6"/></fig></p>
      </sec>
      <sec id="Sec6">
        <title>Discussion</title>
        <p>Primary SFTs in the kidney are extremely rare among previous reports of extrathoracic SFTs [<xref ref-type="bibr" rid="CR8">8</xref>]. Very recently, a growing number of papers on SFT have been published, describing an <italic>NAB2-STAT6</italic> fusion gene in the tumor [<xref ref-type="bibr" rid="CR20">20</xref>&#x2013;<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], the diagnostic relevance of STAT6 or GRIA2 IHC [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>], relationships between fusional variations of the <italic>NAB2-STAT6</italic> gene, histological features and clinical prognosis [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], and expression profiles of genes other than <italic>NAB2-STAT6</italic> [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. However, these reports are based on SFT specimens from case studies that do not include primary renal SFT or do not describe the specific site of isolation. Diffuse positivity of PAX8 in the nuclei of the present SFT may reflect its renal origin (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).</p>
        <p>Originally introduced by England et al. [<xref ref-type="bibr" rid="CR19">19</xref>], the diagnostic criteria for malignant SFT are increased cellularity, pleomorphism, necrosis and hemorrhage, and mitotic activities&#x2009;&gt;&#x2009;4 counts/10 HPFs on microscopy [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. In a retrospective analysis of 83 SFT patients, including 59 extrathoracic SFTs, who underwent surgical resection, Wilky et al. reported that malignant histology was very strongly associated with recurrence, but that extrathoracic location could also independently predict recurrence [<xref ref-type="bibr" rid="CR35">35</xref>]. Therefore, the renal SFT in the present case may have malignant potential, although it is considered benign, both microscopically and clinically, as there has been no distant metastasis or invasion into adjacent tissues in a radical nephrectomy, and no recurrence since the operation. Thus, there is generally no strict correlation between histology and clinical behavior in SFT. It would be more appropriate to describe SFT without malignant nature in histological and clinical presentation as &#x201C;classic&#x201D; SFT rather than &#x201C;benign&#x201D; SFT.</p>
        <p>Renal SFT is presumed to originate from s renal capsule, interstitial or peripelvic connective tissue [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Reported in a review [<xref ref-type="bibr" rid="CR8">8</xref>], the renal capsule is the most common site of the origins. The renal SFT in the present report may occur in intrarenal interstitial tissue because it displayed mostly endophylic growth within the kidney.</p>
        <p>Recently, Barthelme&#xDF; et al. [<xref ref-type="bibr" rid="CR23">23</xref>] demonstrated that different patterns of the <italic>NAB2-STAT6</italic> gene fusion could cause specific histology and distinct clinical behaviors in SFT. In their report, twelve different <italic>NAB2-STAT6</italic> fusion variants were identified in 48 of 52 study patients. These were classified by microscopy into three groups, <italic>NAB2</italic> exon4-<italic>STAT6</italic> exon2/3 (n&#x2009;=&#x2009;27), <italic>NAB2</italic> exon6-<italic>STAT6</italic> exon16/17 (n&#x2009;=&#x2009;11), and other patterns (n&#x2009;=&#x2009;10). The first group corresponded to classic thoracic SFT with diffuse fibrosis and non-malignant nature. The second group represented SFT from deep soft tissue with aggressive behavior and poor prognosis. The recurrence rates in the two groups were 15 % and 64 %, respectively (p&#x2009;&lt;&#x2009;0.016) [<xref ref-type="bibr" rid="CR23">23</xref>]. With a <italic>NAB2</italic> exon2 (internal)-<italic>STAT6</italic> exon3 fusion, the renal SFT in our case was consistent with Barthelme&#x3B2; et al.&#x2019;s third group of other variants of <italic>NAB2-STAT6</italic> gene fusions. On average, the third group had mitotic counts of 1.0/10 HPFs, a tumor diameter of 3.7&#xA0;cm and classic characters for SFT in microscopic examination. However, it had a clinical recurrence rate of 10 % over a mean postoperative follow-up of 7.8&#xA0;years [<xref ref-type="bibr" rid="CR23">23</xref>]. Late recurrence &#x2265;10&#xA0;years after initial diagnosis can occur in SFT and some cases can behave aggressively even in the absence of any primary morphologic evidence of malignancy [<xref ref-type="bibr" rid="CR36">36</xref>]. In our case, only two recurrence-free years with regular medical follow-up have elapsed since radical nephrectomy. Therefore, long-term follow-up should be recommended because the probability of future tumor recurrence in our patient cannot be definitively excluded. On the other hand, careful attention must be paid when directly extrapolating their results for the renal SFT in presented here. One reason caution is required is that their findings were based on the analysis of SFT samples with non-renal primary origins. Secondly, <italic>NAB2-STAT6</italic> gene fusions were not necessarily detected in about 10&#x2013;50 % of patients with SFT [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], implicating that abnormal fusion of the <italic>NAB2-STAT6</italic> gene is not be essential and sufficient for oncogenesis in SFTs. Currently, variations of the <italic>NAB2-STAT6</italic> gene fusion cannot explain clear relationships in tumorigenesis, the preponderance of the thoracic origin, or the malignant behavior of SFT.</p>
        <p>Differentiation and definitive diagnosis of SFT from other soft tissue tumors has been regarded as difficult due to histological similarities [<xref ref-type="bibr" rid="CR4">4</xref>]. IHC against CD34, CD99, and Bcl-2 are often used as supportive diagnostic stains for SFT, and 90&#x2013;95 %, 70 %, and 20&#x2013;35 % of SFT cases are positive, respectively [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. However, other soft tissue tumors are also frequently positive for CD34, CD99, and Bcl-2, rendering these antigens non-specific for SFT [<xref ref-type="bibr" rid="CR4">4</xref>]. Dedifferentiated liposarcoma, which shows the similar morphology to SFT on microscopy, was differentiated because IHC for MDM2 and CDK4 was negative in the present case [<xref ref-type="bibr" rid="CR37">37</xref>]. Analysis of IHC on a large number of sarcomas reported a sensitivity of 95 % and 92 % and a specificity of 81 % and 95 % for, respectively, MDM2 and CDK4 for the diagnosis of dedifferentiated liposarcoma [<xref ref-type="bibr" rid="CR37">37</xref>]. Based on evidence that a <italic>NAB2-STAT6</italic> gene fusion is present in most SFT cases, NAB2 and STAT6 IHC have recently been reported in 100 % [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] and 86&#x2013;100 % [<xref ref-type="bibr" rid="CR23">23</xref>&#x2013;<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] of SFT cases. Surprisingly, only 2.3&#x2013;2.5 % of non-SFT soft tissue tumors exhibited positive and weak reactions in IHC with anti-STAT6 antibodies [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Thus, STAT6 IHC could be a valuable diagnostic standard for the NAB2-STAT6 fusion protein in SFT [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Vivero et al. demonstrated that GRIA2 was a useful marker for distinguishing SFT from most mimics, as 89 % of SFTs were GRIA2-positive, while only 5&#x2013;10 % of other soft tissue tumors were positive, except for dermatofibrosarcoma and myoepithelioma [<xref ref-type="bibr" rid="CR4">4</xref>]. In their report, a noteworthy case of SFT proven to have the <italic>NAB2-STAT6</italic> gene fusion was STAT6-negative but GRIA2-positive in IHC.</p>
        <p>In normal cells, <italic>NAB2</italic> and <italic>STAT6</italic> are located close together on chromosome 12 and transcribed in opposite directions [<xref ref-type="bibr" rid="CR26">26</xref>]. STAT6 and NAB2 function antagonistically as a transcription activator and a repressor, respectively, regulating wound healing and fibrosis via early growth response 1-mediated pathways [<xref ref-type="bibr" rid="CR26">26</xref>]. GRIA2, a glutamate receptor subunit, affects cell membrane calcium permeability, cell proliferation, motility, and cell death [<xref ref-type="bibr" rid="CR4">4</xref>]. GRIA2 is normally expressed in the central nervous system under physiological conditions, but GRIA2 can be detected in various oncogenic conditions via unknown mechanisms [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. In the present study, the renal SFT, which had a <italic>NAB2-STAT6</italic> gene fusion identified by direct sequencing, was stained positively with anti-NAB2, -STAT6, and -GRIA2 antibodies in IHC. However, one pleural SFT, used as a positive IHC control in the present analysis, was negative for NAB2 and STAT6 in IHC but positive for GRIA2. This finding of reciprocal staining of STAT6 and GRIA2 in SFT may lead the future identification of an alternative pathway of tumorigenesis in SFT. Our findings are based on a renal SFT and two pleural SFT cases. Similar to remarks from Kuroda et al. [<xref ref-type="bibr" rid="CR7">7</xref>], we also think that a broader investigation will be necessary to clarify the etiology of SFT and discuss its clinical characteristics and prognosis.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="conclusions">
      <title>Conclusions</title>
      <p>For the first time, we have reported a case of GRIA2-positive SFT occurring primarily in the kidney with a <italic>NAB2</italic> (exon 2, internal)-<italic>STAT6</italic> (exon 3) gene fusion for the first time. It might present with tumor background of a renal origin that the tumor cells in the present SFT expressed diffusely not only STAT6, NAB2 and GRIA2 but also PAX8. Indeed, clinical prognosis cannot be necessarily predicted by classic/non-malignant histology of SFT, but analysis of genetic alterations in SFT would help to ameliorate prognostic prediction of the tumor. In the present case, long-term follow-up should be performed after radical nephrectomy, as classic SFT from an extrathoracic origin may have malignant potential.</p>
    </sec>
    <sec id="Sec8">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case Report, any accompanying images, clinical data, and results of the tumor gene analysis. A copy of the written consent is available for review from the Editor-in-Chief of this journal.</p>
      <p>The present study was performed in accordance with the principles embodied in the Declaration of Helsinki and approved by the Ethical Committee of Yamagata University Faculty of Medicine (approval No.6, 2015).</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec9">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="13000_2015_386_MOESM1_ESM.pdf" id="MOESM1">
              <label>Additional file 1:</label>
              <caption>
                <p>
<bold>Methods for immunohistochemistry, identification of</bold>
<bold><italic>NAB2-STAT6</italic></bold>
<bold>gene fusion and in situ proximity ligation brightfield assay.</bold> (PDF 67 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13000_2015_386_MOESM2_ESM.pdf" id="MOESM2">
              <label>Additional file 2:</label>
              <caption>
                <p>
<bold>Primers used for reverse transcription-polymerase chain reaction and direct DNA sequencing.</bold>&#xA0;(PDF 31 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13000_2015_386_MOESM3_ESM.png" id="MOESM3">
              <label>Additional file 3:</label>
              <caption>
                <p>
<bold>Results of reverse transcription-polymerase chain reaction (RT-PCR).</bold> Fusion of the <italic>NAB2-STAT6</italic> gene was detected by RT-PCR with several sets of specifically designed forward and reverse PCR primers. Sequences of the PCR primers are given in Additional file <xref rid="MOESM2" ref-type="media">2</xref>. SFT, solitary fibrous tumor. (PNG 73 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="13000_2015_386_MOESM4_ESM.png" id="MOESM4">
              <label>Additional file 4:</label>
              <caption>
                <p>
<bold>Summary of the </bold>
<bold><italic>NAB2-STAT6</italic></bold>
<bold>gene fusion and PCR primers used in the present study.</bold> (PNG 64 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviation</title>
      <def-list>
        <def-item>
          <term>CT</term>
          <def>
            <p>Computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>GRIA2</term>
          <def>
            <p>Glutamate receptor, inotropic, AMPA 2</p>
          </def>
        </def-item>
        <def-item>
          <term>IHC</term>
          <def>
            <p>Immunohistochemistry</p>
          </def>
        </def-item>
        <def-item>
          <term>NAB2</term>
          <def>
            <p>NGFI-A binding protein 2</p>
          </def>
        </def-item>
        <def-item>
          <term>RCC</term>
          <def>
            <p>Renal cell carcinoma</p>
          </def>
        </def-item>
        <def-item>
          <term>RT-PCR</term>
          <def>
            <p>Reverse transcription-polymerase chain reaction</p>
          </def>
        </def-item>
        <def-item>
          <term>SFT</term>
          <def>
            <p>Solitary fibrous tumor</p>
          </def>
        </def-item>
        <def-item>
          <term>STAT6</term>
          <def>
            <p>Signal transducer and activator of transcription 6</p>
          </def>
        </def-item>
        <def-item>
          <term>USG</term>
          <def>
            <p>Ultrasonography</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>OI participated in the design of the study and drafted the manuscript. HI performed the immunohistochemistry and molecular genetic studies, and drafted the manuscript. MY made differential diagnosis for the tumor. ST, SN and TK participated in clinical data acquisition and management. SN, TK and AN conceived the study, participated in its design and coordination, and helped with drafting the manuscript. All authors have read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We greatly appreciate the excellent technical support of Dr. Naing Ye Aung at the Department of Pathological Diagnostics at the Yamagata University Faculty of Medicine. We thank Assistant Professors Hisashi Kawazoe and Tomohiro Shibasaki at the Department of Urology at the Yamagata University Faculty of Medicine for clinical cooperation.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Solitary fibrous tumour--everywhere, and a diagnosis in vogue</article-title>
          <source>Histopathology</source>
          <year>1997</year>
          <volume>31</volume>
          <issue>6</issue>
          <fpage>568</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2559.1997.2400897.x</pub-id>
          <pub-id pub-id-type="pmid">9447390</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klemperer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rabin</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Primary neoplasms of the pleura. A report of five cases</article-title>
          <source>Arch Pathol</source>
          <year>1931</year>
          <volume>11</volume>
          <fpage>385</fpage>
          <lpage>412</lpage>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez Cruz</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Hernandez Sanchez</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Blazquez</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Prieto Nogal</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Gomez Tejeda</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Malignant solitary fibrous kidney tumor with peritoneal disease: a case report</article-title>
          <source>Case Rep Nephrol Urol</source>
          <year>2014</year>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>70</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1159/000362539</pub-id>
          <pub-id pub-id-type="pmid">24876832</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vivero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hornick</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling</article-title>
          <source>Histopathology</source>
          <year>2014</year>
          <volume>65</volume>
          <issue>1</issue>
          <fpage>71</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1111/his.12377</pub-id>
          <pub-id pub-id-type="pmid">24456377</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koelsche</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schweizer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Renner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Warth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Sahm</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour</article-title>
          <source>Histopathology</source>
          <year>2014</year>
          <volume>65</volume>
          <issue>5</issue>
          <fpage>613</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1111/his.12431</pub-id>
          <pub-id pub-id-type="pmid">24702701</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gelb</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Weidner</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Solitary fibrous tumor involving the renal capsule</article-title>
          <source>Am J Surg Pathol</source>
          <year>1996</year>
          <volume>20</volume>
          <issue>10</issue>
          <fpage>1288</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199610000-00016</pub-id>
          <pub-id pub-id-type="pmid">8827037</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuroda</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sakaida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Uemura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nagashima</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Solitary fibrous tumor of the kidney with focus on clinical and pathobiological aspects</article-title>
          <source>Int J Clin Exp Pathol</source>
          <year>2014</year>
          <volume>7</volume>
          <issue>6</issue>
          <fpage>2737</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">25031693</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khater</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Khauli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shahait</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Degheili</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Khalifeh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Aoun</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Solitary fibrous tumors of the kidneys: presentation, evaluation, and treatment</article-title>
          <source>Urol Int</source>
          <year>2013</year>
          <volume>91</volume>
          <issue>4</issue>
          <fpage>373</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1159/000354394</pub-id>
          <pub-id pub-id-type="pmid">24008397</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Znati</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chbani</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>El Fatemi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Harmouch</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kamaoui</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tazi</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Solitary fibrous tumor of the kidney: a case report and review of the literature</article-title>
          <source>Rev Urol</source>
          <year>2007</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>36</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">17396171</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fine</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Argani</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Malignant solitary fibrous tumor of the kidney: report of a case and comprehensive review of the literature</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2006</year>
          <volume>130</volume>
          <issue>6</issue>
          <fpage>857</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">16740040</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Dhalla</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Khashab</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>Pancreatic metastasis from a solitary fibrous tumor of the kidney: a rare cause of acute recurrent pancreatitis</article-title>
          <source>Pancreatology</source>
          <year>2013</year>
          <volume>13</volume>
          <issue>6</issue>
          <fpage>631</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pan.2013.06.004</pub-id>
          <pub-id pub-id-type="pmid">24280583</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mearini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cochetti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Barillaro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fatigoni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roila</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Renal malignant solitary fibrous tumor with single lymph node involvement: report of unusual metastasis and review of the literature</article-title>
          <source>Onco Targets Ther.</source>
          <year>2014</year>
          <volume>7</volume>
          <fpage>679</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">24855378</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cuello</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bruges</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Malignant solitary fibrous tumor of the kidney: report of the first case managed with interferon</article-title>
          <source>Case Rep Oncol Med.</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>564980</fpage>
          <pub-id pub-id-type="pmid">23401821</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kurihara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Katsuoka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyano</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distant metastasis from benign solitary fibrous tumor of the kidney</article-title>
          <source>Case Rep Nephrol Urol</source>
          <year>2013</year>
          <volume>3</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1159/000346850</pub-id>
          <pub-id pub-id-type="pmid">23466873</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Martino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bohm</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klatte</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Malignant solitary fibrous tumour of the kidney: report of a case and cumulative analysis of the literature</article-title>
          <source>Aktuelle Urol</source>
          <year>2012</year>
          <volume>43</volume>
          <issue>1</issue>
          <fpage>59</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1055/s-0030-1283853</pub-id>
          <pub-id pub-id-type="pmid">22271338</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>ZH</given-names>
            </name>
          </person-group>
          <article-title>Clinical characteristics of malignant solitary fibrous tumors of the kidney with thoracic vertebral metastasis</article-title>
          <source>Int J Urol</source>
          <year>2012</year>
          <volume>19</volume>
          <issue>2</issue>
          <fpage>177</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1442-2042.2011.02921.x</pub-id>
          <pub-id pub-id-type="pmid">22171612</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sfoungaristos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Papatheodorou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kavouras</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Perimenis</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Solitary fibrous tumor of the kidney with massive retroperitoneal recurrence. A case presentation</article-title>
          <source>Prague Med Rep</source>
          <year>2012</year>
          <volume>113</volume>
          <issue>3</issue>
          <fpage>246</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">22980566</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leroy</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Copin</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Coindre</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Meria</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wacrenier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gosset</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Solitary fibrous tumour of the kidney</article-title>
          <source>Urol Int</source>
          <year>2000</year>
          <volume>65</volume>
          <issue>1</issue>
          <fpage>49</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1159/000064835</pub-id>
          <pub-id pub-id-type="pmid">10965303</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>England</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Hochholzer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1989</year>
          <volume>13</volume>
          <issue>8</issue>
          <fpage>640</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-198908000-00003</pub-id>
          <pub-id pub-id-type="pmid">2665534</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Kalyana-Sundaram</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lonigro</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>YS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing</article-title>
          <source>Nat Genet</source>
          <year>2013</year>
          <volume>45</volume>
          <issue>2</issue>
          <fpage>180</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2509</pub-id>
          <pub-id pub-id-type="pmid">23313952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chmielecki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Crago</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O'Connor</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ambrogio</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors</article-title>
          <source>Nat Genet</source>
          <year>2013</year>
          <volume>45</volume>
          <issue>2</issue>
          <fpage>131</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2522</pub-id>
          <pub-id pub-id-type="pmid">23313954</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mohajeri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tayebwa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Collin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Magnusson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>von Steyern</surname>
              <given-names>FV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2013</year>
          <volume>52</volume>
          <issue>10</issue>
          <fpage>873</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1002/gcc.22083</pub-id>
          <pub-id pub-id-type="pmid">23761323</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barthelme&#x3B2;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Geddert</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Boltze</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moskalev</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Bieg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sirbu</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features</article-title>
          <source>Am J Pathol</source>
          <year>2014</year>
          <volume>184</volume>
          <issue>4</issue>
          <fpage>1209</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajpath.2013.12.016</pub-id>
          <pub-id pub-id-type="pmid">24513261</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akaike</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kurisaki-Arakawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Suehara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mitani</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential</article-title>
          <source>Hum Pathol</source>
          <year>2015</year>
          <volume>46</volume>
          <issue>3</issue>
          <fpage>347</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2014.11.018</pub-id>
          <pub-id pub-id-type="pmid">25582503</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsuta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Narita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawai</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors</article-title>
          <source>Am J Surg Pathol</source>
          <year>2014</year>
          <volume>38</volume>
          <issue>4</issue>
          <fpage>552</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0000000000000137</pub-id>
          <pub-id pub-id-type="pmid">24625420</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doyle</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Vivero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CDM</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hornick</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics</article-title>
          <source>Mod Pathol</source>
          <year>2014</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>390</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">24030747</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kutikov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Uzzo</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth</article-title>
          <source>J Urol</source>
          <year>2009</year>
          <volume>182</volume>
          <issue>3</issue>
          <fpage>844</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1016/j.juro.2009.05.035</pub-id>
          <pub-id pub-id-type="pmid">19616235</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="other">Klatte T, Ficarra V, Gratzke C, Kaouk J, Kutikov A, Macchi V et al. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy. Eur Urol. 2015. doi:10.1016/j.eururo.2015.04.010.</mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demicco</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Harms</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Ingram</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extensive survey of STAT6 expression in a large series of mesenchymal tumors</article-title>
          <source>Am J Clin Pathol</source>
          <year>2015</year>
          <volume>143</volume>
          <issue>5</issue>
          <fpage>672</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1309/AJCPN25NJTOUNPNF</pub-id>
          <pub-id pub-id-type="pmid">25873501</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kohashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bekki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ishii</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Iura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maekawa</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Malignant solitary fibrous tumor with high-grade nuclear atypia: an alternate entity for the undetermined tumor group</article-title>
          <source>Pathol Res Pract</source>
          <year>2015</year>
          <volume>211</volume>
          <issue>2</issue>
          <fpage>117</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prp.2014.12.002</pub-id>
          <pub-id pub-id-type="pmid">25554652</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mertens</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tayebwa</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Evolving techniques for gene fusion detection in soft tissue tumours</article-title>
          <source>Histopathology</source>
          <year>2014</year>
          <volume>64</volume>
          <issue>1</issue>
          <fpage>151</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1111/his.12272</pub-id>
          <pub-id pub-id-type="pmid">24320890</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsukamoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nishimoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kakibuchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kohashi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>STAT6-positive intraorbital papillary tumor: a rare variant of solitary fibrous tumor?</article-title>
          <source>Pathol Res Pract</source>
          <year>2014</year>
          <volume>210</volume>
          <issue>7</issue>
          <fpage>450</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prp.2014.03.001</pub-id>
          <pub-id pub-id-type="pmid">24703527</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schweizer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Koelsche</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sahm</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Piro</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Capper</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Reuss</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein</article-title>
          <source>Acta Neuropathol</source>
          <year>2013</year>
          <volume>125</volume>
          <issue>5</issue>
          <fpage>651</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-013-1117-6</pub-id>
          <pub-id pub-id-type="pmid">23575898</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertucci</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bouvier-Labit</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Finetti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Metellus</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Adelaide</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mokhtari</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene expression profiling of solitary fibrous tumors</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>5</issue>
          <fpage>e64497</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0064497</pub-id>
          <pub-id pub-id-type="pmid">23734203</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilky</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Guzzetta</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Ahuja</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Extrathoracic location and "borderline" histology are associated with recurrence of solitary fibrous tumors after surgical resection</article-title>
          <source>Ann Surg Oncol</source>
          <year>2013</year>
          <volume>20</volume>
          <issue>13</issue>
          <fpage>4080</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1245/s10434-013-3241-x</pub-id>
          <pub-id pub-id-type="pmid">24046107</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baldi</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Stacchiotti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mauro</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dei Tos</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Gronchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pastorino</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients</article-title>
          <source>Clin Sarcoma Res.</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>4</fpage>
          <pub-id pub-id-type="doi">10.1186/2045-3329-3-4</pub-id>
          <pub-id pub-id-type="pmid">23551825</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coindre</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Pedeutour</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Aurias</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Well-differentiated and dedifferentiated liposarcomas</article-title>
          <source>Virchows Arch</source>
          <year>2010</year>
          <volume>456</volume>
          <issue>2</issue>
          <fpage>167</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-009-0815-x</pub-id>
          <pub-id pub-id-type="pmid">19688222</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
